- Home
- BRID vs SRZN Comparison
BRID vs SRZN Comparison
Compare BRID & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRID
- SRZN
- Stock Information
- Founded
- BRID 1932
- SRZN 2015
- Country
- BRID United States
- SRZN United States
- Employees
- BRID N/A
- SRZN N/A
- Industry
- BRID Specialty Foods
- SRZN Medicinal Chemicals and Botanical Products
- Sector
- BRID Consumer Staples
- SRZN Health Care
- Exchange
- BRID Nasdaq
- SRZN Nasdaq
- Market Cap
- BRID 70.3M
- SRZN 72.8M
- IPO Year
- BRID N/A
- SRZN N/A
- Fundamental
- Price
- BRID $7.93
- SRZN $8.36
- Analyst Decision
- BRID
- SRZN Strong Buy
- Analyst Count
- BRID 0
- SRZN 2
- Target Price
- BRID N/A
- SRZN $38.50
- AVG Volume (30 Days)
- BRID 5.5K
- SRZN 23.7K
- Earning Date
- BRID 08-22-2025
- SRZN 08-11-2025
- Dividend Yield
- BRID N/A
- SRZN N/A
- EPS Growth
- BRID N/A
- SRZN N/A
- EPS
- BRID N/A
- SRZN N/A
- Revenue
- BRID $224,673,000.00
- SRZN $11,638,000.00
- Revenue This Year
- BRID N/A
- SRZN N/A
- Revenue Next Year
- BRID N/A
- SRZN N/A
- P/E Ratio
- BRID N/A
- SRZN N/A
- Revenue Growth
- BRID N/A
- SRZN N/A
- 52 Week Low
- BRID $7.50
- SRZN $5.90
- 52 Week High
- BRID $14.69
- SRZN $18.17
- Technical
- Relative Strength Index (RSI)
- BRID 50.67
- SRZN 43.79
- Support Level
- BRID $7.78
- SRZN $8.38
- Resistance Level
- BRID $8.74
- SRZN $9.88
- Average True Range (ATR)
- BRID 0.23
- SRZN 0.77
- MACD
- BRID 0.00
- SRZN -0.07
- Stochastic Oscillator
- BRID 34.68
- SRZN 17.14
About BRID Bridgford Foods Corporation
Bridgford Foods Corp manufactures, markets, and distributes frozen and snack food products in the United States. The business segments are; the processing and distribution of frozen products, and the processing and distribution of snack food products. Its product offerings include meat snacks, breads and rolls, biscuits, and ready-to-eat sandwiches among others. The company offers frozen food products to the foodservice and retail customers through wholesalers, cooperatives, and distributors; and snack food items to supermarkets, and mass merchandise and convenience retail stores through customer-owned distribution centers, as well as a direct store delivery network. A majority of the company's revenue is derived from the snack food products segment.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).